<DOC>
	<DOCNO>NCT02646969</DOCNO>
	<brief_summary>Growth metabolic biomarkers healthy term infant feed formula stag protein concentration first year life</brief_summary>
	<brief_title>Growth Metabolic Biomarkers Healthy Term Infants Fed Formulas With Staged Protein Concentrations Over First Year Life</brief_title>
	<detailed_description>The overall objective study assess growth biomarkers energy protein metabolism healthy term infant feed two different study formula regimens birth 12 month age follow infant 4 year age .</detailed_description>
	<criteria>Healthy infant enrol study provide meet follow inclusion criterion : 1 . Having obtain his/her parent ' ( his/her legally accept representative 's [ LAR 's ] ) write informed consent evidence personally sign date informed consent document indicate infant 's parents/LAR inform pertinent aspect study . 2 . Age ≤ 7 day birth ( date birth = Day 0 ) 3 . Fullterm gestational birth ( ≥ 37 ≤ 42 week ) 4 . Born mother prepregnancy body mass index ( BMI ) ≥ 18.5 &lt; 26 kg/m2 5 . Born mother independently elect , study enrollment , breastfeed ( applicable infant HMfed comparator group ) 6 . Weight ≥ 2'500 g ≤ 4'200 g 7 . Infant 's parent ( ) /LAR legal age consent , sufficient command French language complete inform consent study document , willing able fulfill requirement study protocol 8 . Infant 's parent ( ) /LAR able contact directly telephone throughout study Infants exhibit one follow criterion exclude enrollment study : 1 . Born mother hormonal metabolic disease ( e.g . Type1 , Type2 , gestational diabetes diagnose accord standardized criterion ) 2 . Born mother smoke &gt; 10 cigarette per day pregnancy 3 . Born mother use illicit drug ( e.g . marijuana , cocaine , amphetamine , heroin ) alcohol ( &gt; 3 alcoholic beverage per week ) pregnancy 4 . Cognitive physical developmental disorder ( e.g . malabsorptive disorder short bowel syndrome ; neurological congenital disorder may delay growth cerebral palsy , agenesis corpus callosum , spina bifida , Down Syndrome , Cri Du Chat ; disorder may lead obesity Prader willi syndrome , Angelman syndrome ; renal , hepatic , pancreatic , cardiovascular disorder ) 5 . Received radiation therapy ( eg . scannography interventional radiology ) 6 . Participation clinical trial prior enrollment 7 . Infants infant 's family Investigator 's judgment expect comply protocol study procedure</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>7 Days</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>